SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 14.86 |
| Enterprise Value ($M) | -13.35 |
| Book Value ($M) | 44.13 |
| Book Value / Share | 2.77 |
| Price / Book | 0.34 |
| NCAV ($M) | 42.62 |
| NCAV / Share | 2.67 |
| Price / NCAV | 0.35 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.95 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.47 |
| Current Ratio | 4.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 54.91 |
| Assets | 56.42 |
| Liabilities | 12.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.50 |
| Operating Income | -43.64 |
| Net Income | -39.83 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -33.97 |
| Cash from Investing | 23.36 |
| Cash from Financing | -0.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Cormorant Asset Management, LP | 9.99 | ||
| 13G/A | Citadel Advisors Llc | 7.20 | ||
| 13G/A | Soleus Capital Master Fund, L.P. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 88,524 | 235,189 | 37.64 | |
| 19,811 | 89,212 | 22.21 | |
| 25,408 | 111,752 | 22.74 | |
| 31,739 | 104,133 | 30.48 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VTGN – Vistagen Therapeutics, Inc. | VTVT – vTv Therapeutics Inc. |
| VXRT – Vaxart, Inc. | WHWK – Whitehawk Therapeutics, Inc. |
| WINT – Windtree Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io